| Dates | Principal Investigator(s) |
Grant No./ Donor |
Title |
|---|---|---|---|
| 7/17-6/22 | Alex Lippert, PhD (SMU) Local PI: Ralph Mason, PhD |
NSF 1653474; subcontract from Southern Methodist University | Triggered Energy Transfer Chemiluminescence for In Vivo Imaging |
| 7/19-6/21 | Leo L Cheng, PhD (MGH) Local PI: Ralph Mason, PhD |
R21 CA243255, NIH/NCI; subcontract from Massachusetts General Hospital | Probing Prostate Cancer Bioactivity with Polyamine Dynamics |
| 9/17-8/20 | Evan Unger, MD | 2R44CA144817-03 | Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation |
| 6/12-4/17 | Ralph Mason, PhD | RP120670-P3, CPRIT | Effects of Hypoxia: Project 3 in Exploiting the Radiobiology of Sterotactic Ablative Radiotherapy for Lung Cancer |
| 12/14-11/17 | Kevin Pinney, Ph.D. (Baylor University) Ralph Mason, PhD |
RP 140399 CPRIT-IIRA; (Subcontract from Baylor University) | Targeting Hypoxia in Breast Cancer with Highly Potent Small-Molecule Anticancer Prodrugs |
| 8/14-8/17 | Ralph Mason, PhD | RP140285, CPRIT | Noninvasive Identification of Prostate Tumor Hypoxia as a Prognostic Biomarker of Radiation Response |
| 6/11-4/16 | Ralph Mason, PhD | RP110441-C1, CPRIT | C1: In Vivo Imaging Core |
| 8/10-7/15 | James K.V. Willson, M.D. | P30 CA142543-01, NIH/NCI | Cancer Center Support Grant |
| 6/10-3/15 | Kevin G. Pinney, Ph.D. (Baylor University); Ralph Mason, PhD |
1 R01 CA140674-01, NIH/NCI; Subcontract with Baylor | Discovery and development of improved chemotherapeutic agents with enhanced selectivity for the tumor microenvironment |
| 1/10-12/14 | Ralph Mason, PhD | R01 CA139043-01A1, NIH/NCI | Hypoxia and radiotherapy: Evaluation and mitigation in tumors |
| 4/07-3/13 | Ralph Mason, PhD | U24CA126608A – SAIRP, NIH/NCI | UT Southwestern Small Animal Imaging Resource |
| 8/09-7/12 | Jian Yang, Ph.D. (UT Arlington) Ralph Mason, PhD |
R21 EB009795-01, NIH/NIBIB; (Subcontract with UT Arlington) |
Enabling aliphatic biodegradable photoluminescent polymeric biomaterials |
| 5/08-5/11 | Robert Timmerman, M.D. | PC074348, USDOD | Stereotactic body radiation therapy for underserved populations of men with low- and intermediate-risk prostate cancer. |
| 4/09-3/11 | Philip Thorpe, Ph.D. | PC081501, USDOD | Targeting phosphatidylserine to improve hormone therapy of prostate cancer |
| 3/09-2/11 | Vikram D. Kodibagkar, Ph.D. | 1R21 CA132096-01A1; NIH, NCI | 1H MRI based nanosensors for imaging tumor oxygenation |
| 4/07-11/10 | Ralph Mason, PhD | 1R21CA120774-01A1, NIH/NCI | MAGIC – Magnetic Resonance Assessment of Gene Imaging Constructs |
| 4/06-6/10 | Ralph Mason, PhD | BC051255 – W81XWH-06-1-0475, DOD Breast Cancer Initiative: IDEA Development Award (no cost extension) | Breast tumor detection and treatment using Tarvacin labeled with arsenic radionuclides |
| 5/09-4/10 | Ralph Mason, PhD | 1S10RR02564801, ARRA-NIH | Small Animal Ultrasound System (VisualSonics Vevo 770) |
| 8/07-2/10 | Ralph Mason, PhD | 081-07, The Mary Kay Ash Charitable Foundation | Predicting treatment response for cervical cancer: Non-invasive assessment using bold MRI |
| 9/05-12/09 | Ralph Mason, PhD | PC050766 – W81XWH-06-1-0149, DOD Prostate Cancer Initiative: IDEA Development Award (IDA) | Vatuximab™: Optimizing therapeutic strategies for prostate cancer based on dynamic MR tumor oximetry |
| 9/07-9/08 | Ralph Mason, PhD | 1S10RR024757-01, NIH Shared Instrumentation Grant | Small animal bioluminescence and fluorescence imaging system (with 3D capability) |
| 3/99-2/04 | Ralph Mason, PhD | NIH 1R01 CA79515 | MR Measurement of tumor pH, pO2 and vascularity in vivo |
| 5/01 – 4/04 | Ralph Mason, PhD | 1P20 CA086354 | NCI in vivo Cellular and Molecular Imaging Center (Pre-ICMIC) |
| 10/99 – 9/02 | Ralph Mason, PhD | DOD Breast Cancer Initiative BC980020 DAMD17-99-1-9381 | Breast tumor pH: design evaluation and application of novel reporter molecules |
| 2000 – 2003 | Dr. Li Liu | DOD BRCA IDEA grant BC990287 | Non-invasive monitoring of breast tumor oxygenation: A key to tumor therapy planning and tumor prognosis |
| 3/00-2/03 | Dr. Abbott; Mentor: Ralph Mason, PhD | DOD Breast Cancer Initiative Predoctoral fellowship BC990911 | An Investigation of Breast Tumor Vasculature using Magnetic Resonance Microscopy |
| Ralph Mason, PhD | 5-P41-RR02584 99-02 | NIH Biotechnology Research Technology program: service projects | |
| 5/01 – 4-03 | PI: Dawen Zhao, MD PhD; Mentor: Ralph Mason, PhD | Correlation of tumor oxygenation and angiogenesis: implications for therapy | |
| 9/89 – 8/90 | Ralph Mason, PhD | Institutional Research Grant from UT Southwestern | A non-invasive determination of oxygen tension in vivo: the use of 19F NMR spectroscopy to observe sequestered Fluosol-DA in the perfused heart |
| 7/90 – 6/92 | Ralph Mason, PhD | American Heart Association (TX Affiliate) 90G-079 | A non-invasive assessment of myocardial oxygen tension |
| 10/91 – 9/92 | Ralph Mason, PhD | American Cancer Society Grant IN-142: administered by UTSW | Glutathione: non-invasive determination in the growing tumor |
| 1/92 – 12/92 | Ralph Mason, PhD | Access Pharmaceuticals Inc. | Unrestricted gift for Research & Development in MRI |
| 7/92 – 6/93 | Ralph Mason, PhD | Alliance Pharmaceutical Corporation | Optimal exploitation of Oxygent to measure pO2 and temperature in vivo at 4.7 Tesla |
| 7/93 – 6/96 | Ralph Mason, PhD | American Heart Association (TX Affiliate): 93G-082, Lyndon Baines Johnson Prize Awardee | A novel approach to measuring local myocardial oxygen tension |
| 1/94 – 12/94 | Ralph Mason, PhD | Cambridge Isotopes Limited | Prostate cancer: diagnosis using 1H DQCT and 13C NMR of citrate |
| 7/96 – 10/96 | Ralph Mason, PhD | National Osteoporosis Foundation: student fellowship | Bone structure/function relationship by MR microscopy and ultrasound elastometry |
| 7/94 – 1/98 | Ralph Mason, PhD | The Whitaker Foundation | Innovative approaches to tissue oximetry: 19F NMR of perfluorocarbons |
| 4/98 – 3/99 | Ralph Mason, PhD | The Whitaker Foundation | Integrated Tissue Physiology by NMR |
| 7/97-6/01 | Ralph Mason, PhD | American Cancer Society: RPG-97-116-010CCE | Tumor Oximetry: mapping oxygenation dynamics by 19F magnetic resonance |
| 10/97 – 6/01 | PI: Yulin Song PhD Mentor: Ralph Mason, PhD | Department of Defense Breast Cancer Research Program: BC962357, DAMD17-97-1-7261 Student doctoral fellowship 1996 |
Non-invasive determination of breast cancer oxygen tension by F-19 NMR and Breast Cancer physiology in response to radiotherapy |